nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—POU2F2—Ectoderm Differentiation—SIX6—glaucoma	0.0495	0.217	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.0381	0.168	CbGpPWpGaD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—IL1A—glaucoma	0.0183	0.0804	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.0137	0.0601	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—PAX6—glaucoma	0.0115	0.0505	CbGpPWpGaD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—glaucoma	0.011	0.0482	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00978	0.043	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—BDNF—glaucoma	0.0073	0.0321	CbGpPWpGaD
Dolutegravir—UGT1A1—Estrogen metabolism—CYP1B1—glaucoma	0.00709	0.0312	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00701	0.0308	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NGF—glaucoma	0.00648	0.0285	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00645	0.0283	CbGpPWpGaD
Dolutegravir—UGT1A1—Estrogen metabolism—GSTM1—glaucoma	0.00567	0.0249	CbGpPWpGaD
Dolutegravir—Insomnia—Carteolol—glaucoma	0.00391	0.00506	CcSEcCtD
Dolutegravir—Mental disorder—Apraclonidine—glaucoma	0.00373	0.00483	CcSEcCtD
Dolutegravir—Nervous system disorder—Latanoprost—glaucoma	0.00371	0.00481	CcSEcCtD
Dolutegravir—Abnormal dreams—Timolol—glaucoma	0.00369	0.00478	CcSEcCtD
Dolutegravir—Skin disorder—Latanoprost—glaucoma	0.00368	0.00476	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00367	0.00475	CcSEcCtD
Dolutegravir—Fatigue—Diclofenamide—glaucoma	0.00366	0.00474	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Brinzolamide—glaucoma	0.00362	0.00469	CcSEcCtD
Dolutegravir—Renal impairment—Betaxolol—glaucoma	0.00349	0.00451	CcSEcCtD
Dolutegravir—Abdominal pain upper—Clonidine—glaucoma	0.00348	0.00451	CcSEcCtD
Dolutegravir—Hypersensitivity—Metipranolol—glaucoma	0.00344	0.00445	CcSEcCtD
Dolutegravir—Urinary tract disorder—Travoprost—glaucoma	0.00344	0.00445	CcSEcCtD
Dolutegravir—Urethral disorder—Travoprost—glaucoma	0.00341	0.00442	CcSEcCtD
Dolutegravir—Urinary tract disorder—Brinzolamide—glaucoma	0.00339	0.00439	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Methazolamide—glaucoma	0.00338	0.00437	CcSEcCtD
Dolutegravir—Fatigue—Methazolamide—glaucoma	0.00337	0.00437	CcSEcCtD
Dolutegravir—Urethral disorder—Brinzolamide—glaucoma	0.00337	0.00436	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00335	0.0147	CbGpPWpGaD
Dolutegravir—Asthenia—Metipranolol—glaucoma	0.00335	0.00433	CcSEcCtD
Dolutegravir—Immune system disorder—Brimonidine—glaucoma	0.0033	0.00428	CcSEcCtD
Dolutegravir—Hepatitis—Pilocarpine—glaucoma	0.0033	0.00427	CcSEcCtD
Dolutegravir—Abdominal pain—Carbachol—glaucoma	0.00328	0.00424	CcSEcCtD
Dolutegravir—Vertigo—Bimatoprost—glaucoma	0.00323	0.00418	CcSEcCtD
Dolutegravir—Mental disorder—Brimonidine—glaucoma	0.00321	0.00415	CcSEcCtD
Dolutegravir—Hypersensitivity—Carteolol—glaucoma	0.00318	0.00412	CcSEcCtD
Dolutegravir—Immune system disorder—Travoprost—glaucoma	0.00314	0.00407	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00314	0.00406	CcSEcCtD
Dolutegravir—Immune system disorder—Brinzolamide—glaucoma	0.0031	0.00402	CcSEcCtD
Dolutegravir—Asthenia—Carteolol—glaucoma	0.0031	0.00401	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.0031	0.0136	CbGpPWpGaD
Dolutegravir—Dizziness—Metipranolol—glaucoma	0.00308	0.00399	CcSEcCtD
Dolutegravir—Asthenia—Diclofenamide—glaucoma	0.00305	0.00395	CcSEcCtD
Dolutegravir—Mental disorder—Travoprost—glaucoma	0.00305	0.00395	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00304	0.00394	CcSEcCtD
Dolutegravir—Mental disorder—Brinzolamide—glaucoma	0.00301	0.0039	CcSEcCtD
Dolutegravir—Hypersensitivity—Levobunolol—glaucoma	0.00301	0.0039	CcSEcCtD
Dolutegravir—Pruritus—Diclofenamide—glaucoma	0.00301	0.00389	CcSEcCtD
Dolutegravir—Nervous system disorder—Apraclonidine—glaucoma	0.00297	0.00384	CcSEcCtD
Dolutegravir—Flatulence—Brinzolamide—glaucoma	0.00295	0.00381	CcSEcCtD
Dolutegravir—Rash—Metipranolol—glaucoma	0.00294	0.00381	CcSEcCtD
Dolutegravir—Skin disorder—Apraclonidine—glaucoma	0.00294	0.00381	CcSEcCtD
Dolutegravir—Dermatitis—Metipranolol—glaucoma	0.00294	0.0038	CcSEcCtD
Dolutegravir—Asthenia—Levobunolol—glaucoma	0.00293	0.00379	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Betaxolol—glaucoma	0.00293	0.00379	CcSEcCtD
Dolutegravir—Headache—Metipranolol—glaucoma	0.00292	0.00378	CcSEcCtD
Dolutegravir—Pruritus—Levobunolol—glaucoma	0.00289	0.00374	CcSEcCtD
Dolutegravir—Nervous system disorder—Bimatoprost—glaucoma	0.00288	0.00373	CcSEcCtD
Dolutegravir—Dizziness—Carteolol—glaucoma	0.00286	0.0037	CcSEcCtD
Dolutegravir—Skin disorder—Bimatoprost—glaucoma	0.00285	0.00369	CcSEcCtD
Dolutegravir—Diarrhoea—Carbachol—glaucoma	0.00284	0.00367	CcSEcCtD
Dolutegravir—Flatulence—Pilocarpine—glaucoma	0.00283	0.00367	CcSEcCtD
Dolutegravir—Dizziness—Diclofenamide—glaucoma	0.00281	0.00364	CcSEcCtD
Dolutegravir—Asthenia—Methazolamide—glaucoma	0.00281	0.00363	CcSEcCtD
Dolutegravir—Diarrhoea—Levobunolol—glaucoma	0.00279	0.00362	CcSEcCtD
Dolutegravir—Nausea—Metipranolol—glaucoma	0.00277	0.00359	CcSEcCtD
Dolutegravir—Dizziness—Carbachol—glaucoma	0.00274	0.00355	CcSEcCtD
Dolutegravir—Insomnia—Apraclonidine—glaucoma	0.00274	0.00355	CcSEcCtD
Dolutegravir—Vertigo—Dorzolamide—glaucoma	0.00273	0.00354	CcSEcCtD
Dolutegravir—Vertigo—Travoprost—glaucoma	0.00272	0.00352	CcSEcCtD
Dolutegravir—Headache—Carteolol—glaucoma	0.00271	0.00351	CcSEcCtD
Dolutegravir—Vomiting—Diclofenamide—glaucoma	0.0027	0.0035	CcSEcCtD
Dolutegravir—Dizziness—Levobunolol—glaucoma	0.0027	0.0035	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00269	0.00349	CcSEcCtD
Dolutegravir—Vertigo—Brinzolamide—glaucoma	0.00269	0.00348	CcSEcCtD
Dolutegravir—Pruritus—Latanoprost—glaucoma	0.00268	0.00347	CcSEcCtD
Dolutegravir—Rash—Diclofenamide—glaucoma	0.00268	0.00347	CcSEcCtD
Dolutegravir—Diarrhoea—Methazolamide—glaucoma	0.00268	0.00347	CcSEcCtD
Dolutegravir—Headache—Diclofenamide—glaucoma	0.00266	0.00345	CcSEcCtD
Dolutegravir—Insomnia—Bimatoprost—glaucoma	0.00265	0.00344	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TNF—glaucoma	0.00265	0.0117	CbGpPWpGaD
Dolutegravir—Vomiting—Carbachol—glaucoma	0.00264	0.00341	CcSEcCtD
Dolutegravir—Hepatitis—Clonidine—glaucoma	0.00264	0.00341	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC6A13—glaucoma	0.00262	0.0115	CbGpPWpGaD
Dolutegravir—Rash—Carbachol—glaucoma	0.00261	0.00339	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00261	0.00338	CcSEcCtD
Dolutegravir—Dermatitis—Carbachol—glaucoma	0.00261	0.00338	CcSEcCtD
Dolutegravir—Fatigue—Apraclonidine—glaucoma	0.00261	0.00338	CcSEcCtD
Dolutegravir—Headache—Carbachol—glaucoma	0.0026	0.00336	CcSEcCtD
Dolutegravir—Hyperglycaemia—Betaxolol—glaucoma	0.00259	0.00335	CcSEcCtD
Dolutegravir—Nausea—Carteolol—glaucoma	0.00257	0.00332	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00256	0.00332	CcSEcCtD
Dolutegravir—Headache—Levobunolol—glaucoma	0.00256	0.00331	CcSEcCtD
Dolutegravir—Nervous system disorder—Brimonidine—glaucoma	0.00255	0.0033	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00253	0.00328	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00253	0.00327	CcSEcCtD
Dolutegravir—Skin disorder—Brimonidine—glaucoma	0.00252	0.00327	CcSEcCtD
Dolutegravir—Nausea—Diclofenamide—glaucoma	0.00252	0.00327	CcSEcCtD
Dolutegravir—Dizziness—Latanoprost—glaucoma	0.0025	0.00324	CcSEcCtD
Dolutegravir—UGT1A1—Phase II conjugation—GSTT1—glaucoma	0.0025	0.011	CbGpPWpGaD
Dolutegravir—Vomiting—Methazolamide—glaucoma	0.00249	0.00322	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Apraclonidine—glaucoma	0.00248	0.00321	CcSEcCtD
Dolutegravir—Abdominal pain upper—Timolol—glaucoma	0.00248	0.00321	CcSEcCtD
Dolutegravir—Rash—Methazolamide—glaucoma	0.00247	0.00319	CcSEcCtD
Dolutegravir—Dermatitis—Methazolamide—glaucoma	0.00246	0.00319	CcSEcCtD
Dolutegravir—Nausea—Carbachol—glaucoma	0.00246	0.00319	CcSEcCtD
Dolutegravir—Headache—Methazolamide—glaucoma	0.00245	0.00317	CcSEcCtD
Dolutegravir—Nausea—Levobunolol—glaucoma	0.00243	0.00314	CcSEcCtD
Dolutegravir—Nervous system disorder—Travoprost—glaucoma	0.00242	0.00314	CcSEcCtD
Dolutegravir—Skin disorder—Travoprost—glaucoma	0.0024	0.00311	CcSEcCtD
Dolutegravir—Abdominal pain—Apraclonidine—glaucoma	0.00239	0.0031	CcSEcCtD
Dolutegravir—Nervous system disorder—Brinzolamide—glaucoma	0.00239	0.0031	CcSEcCtD
Dolutegravir—Rash—Latanoprost—glaucoma	0.00239	0.00309	CcSEcCtD
Dolutegravir—Dermatitis—Latanoprost—glaucoma	0.00239	0.00309	CcSEcCtD
Dolutegravir—Headache—Latanoprost—glaucoma	0.00237	0.00307	CcSEcCtD
Dolutegravir—Skin disorder—Brinzolamide—glaucoma	0.00237	0.00307	CcSEcCtD
Dolutegravir—Insomnia—Brimonidine—glaucoma	0.00235	0.00304	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00234	0.00303	CcSEcCtD
Dolutegravir—Fatigue—Acetazolamide—glaucoma	0.00233	0.00302	CcSEcCtD
Dolutegravir—Nausea—Methazolamide—glaucoma	0.00232	0.00301	CcSEcCtD
Dolutegravir—Mental disorder—Clonidine—glaucoma	0.00231	0.00299	CcSEcCtD
Dolutegravir—Insomnia—Dorzolamide—glaucoma	0.00225	0.00291	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Brimonidine—glaucoma	0.00224	0.00291	CcSEcCtD
Dolutegravir—Fatigue—Brimonidine—glaucoma	0.00224	0.0029	CcSEcCtD
Dolutegravir—Hypersensitivity—Apraclonidine—glaucoma	0.00223	0.00289	CcSEcCtD
Dolutegravir—Insomnia—Brinzolamide—glaucoma	0.00221	0.00286	CcSEcCtD
Dolutegravir—Asthenia—Apraclonidine—glaucoma	0.00217	0.00281	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—TXN—glaucoma	0.00215	0.00945	CbGpPWpGaD
Dolutegravir—Pruritus—Apraclonidine—glaucoma	0.00214	0.00277	CcSEcCtD
Dolutegravir—Fatigue—Dorzolamide—glaucoma	0.00214	0.00277	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Travoprost—glaucoma	0.00213	0.00276	CcSEcCtD
Dolutegravir—Fatigue—Travoprost—glaucoma	0.00213	0.00276	CcSEcCtD
Dolutegravir—Insomnia—Pilocarpine—glaucoma	0.00212	0.00275	CcSEcCtD
Dolutegravir—Hyperglycaemia—Timolol—glaucoma	0.00211	0.00274	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00211	0.00273	CcSEcCtD
Dolutegravir—Asthenia—Bimatoprost—glaucoma	0.00211	0.00273	CcSEcCtD
Dolutegravir—Fatigue—Brinzolamide—glaucoma	0.0021	0.00272	CcSEcCtD
Dolutegravir—Pruritus—Bimatoprost—glaucoma	0.00208	0.00269	CcSEcCtD
Dolutegravir—Immune system disorder—Betaxolol—glaucoma	0.00207	0.00268	CcSEcCtD
Dolutegravir—Diarrhoea—Apraclonidine—glaucoma	0.00207	0.00268	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Dorzolamide—glaucoma	0.00203	0.00263	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00202	0.00262	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Travoprost—glaucoma	0.00202	0.00262	CcSEcCtD
Dolutegravir—Mental disorder—Betaxolol—glaucoma	0.00201	0.0026	CcSEcCtD
Dolutegravir—Dizziness—Apraclonidine—glaucoma	0.002	0.00259	CcSEcCtD
Dolutegravir—Abdominal pain—Dorzolamide—glaucoma	0.00196	0.00254	CcSEcCtD
Dolutegravir—Abdominal pain—Travoprost—glaucoma	0.00195	0.00253	CcSEcCtD
Dolutegravir—Asthenia—Acetazolamide—glaucoma	0.00194	0.00252	CcSEcCtD
Dolutegravir—Dizziness—Bimatoprost—glaucoma	0.00194	0.00251	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00194	0.00251	CcSEcCtD
Dolutegravir—Vomiting—Apraclonidine—glaucoma	0.00192	0.00249	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Pilocarpine—glaucoma	0.00192	0.00248	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC6A1—glaucoma	0.00192	0.00842	CbGpPWpGaD
Dolutegravir—Hypersensitivity—Brimonidine—glaucoma	0.00191	0.00248	CcSEcCtD
Dolutegravir—Dermatitis—Apraclonidine—glaucoma	0.00191	0.00247	CcSEcCtD
Dolutegravir—Headache—Apraclonidine—glaucoma	0.0019	0.00246	CcSEcCtD
Dolutegravir—Asthenia—Brimonidine—glaucoma	0.00186	0.00241	CcSEcCtD
Dolutegravir—Abdominal pain—Pilocarpine—glaucoma	0.00185	0.0024	CcSEcCtD
Dolutegravir—Diarrhoea—Acetazolamide—glaucoma	0.00185	0.0024	CcSEcCtD
Dolutegravir—Rash—Bimatoprost—glaucoma	0.00185	0.0024	CcSEcCtD
Dolutegravir—Dermatitis—Bimatoprost—glaucoma	0.00185	0.00239	CcSEcCtD
Dolutegravir—Pruritus—Brimonidine—glaucoma	0.00184	0.00238	CcSEcCtD
Dolutegravir—Headache—Bimatoprost—glaucoma	0.00184	0.00238	CcSEcCtD
Dolutegravir—Nervous system disorder—Clonidine—glaucoma	0.00184	0.00238	CcSEcCtD
Dolutegravir—Hypersensitivity—Dorzolamide—glaucoma	0.00183	0.00237	CcSEcCtD
Dolutegravir—Hypersensitivity—Travoprost—glaucoma	0.00182	0.00236	CcSEcCtD
Dolutegravir—Skin disorder—Clonidine—glaucoma	0.00182	0.00236	CcSEcCtD
Dolutegravir—Nausea—Apraclonidine—glaucoma	0.0018	0.00233	CcSEcCtD
Dolutegravir—Hypersensitivity—Brinzolamide—glaucoma	0.0018	0.00233	CcSEcCtD
Dolutegravir—Vertigo—Betaxolol—glaucoma	0.0018	0.00232	CcSEcCtD
Dolutegravir—Dizziness—Acetazolamide—glaucoma	0.00179	0.00232	CcSEcCtD
Dolutegravir—Asthenia—Dorzolamide—glaucoma	0.00178	0.00231	CcSEcCtD
Dolutegravir—Asthenia—Travoprost—glaucoma	0.00177	0.0023	CcSEcCtD
Dolutegravir—Pruritus—Dorzolamide—glaucoma	0.00176	0.00227	CcSEcCtD
Dolutegravir—Asthenia—Brinzolamide—glaucoma	0.00175	0.00227	CcSEcCtD
Dolutegravir—Pruritus—Travoprost—glaucoma	0.00175	0.00226	CcSEcCtD
Dolutegravir—Nausea—Bimatoprost—glaucoma	0.00174	0.00226	CcSEcCtD
Dolutegravir—Hypersensitivity—Pilocarpine—glaucoma	0.00173	0.00224	CcSEcCtD
Dolutegravir—Pruritus—Brinzolamide—glaucoma	0.00173	0.00224	CcSEcCtD
Dolutegravir—Vomiting—Acetazolamide—glaucoma	0.00172	0.00223	CcSEcCtD
Dolutegravir—Dizziness—Brimonidine—glaucoma	0.00172	0.00223	CcSEcCtD
Dolutegravir—Diarrhoea—Dorzolamide—glaucoma	0.0017	0.0022	CcSEcCtD
Dolutegravir—Headache—Acetazolamide—glaucoma	0.0017	0.0022	CcSEcCtD
Dolutegravir—Insomnia—Clonidine—glaucoma	0.00169	0.00219	CcSEcCtD
Dolutegravir—Immune system disorder—Timolol—glaucoma	0.00169	0.00219	CcSEcCtD
Dolutegravir—Diarrhoea—Travoprost—glaucoma	0.00169	0.00219	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00169	0.00219	CcSEcCtD
Dolutegravir—Asthenia—Pilocarpine—glaucoma	0.00168	0.00218	CcSEcCtD
Dolutegravir—Diarrhoea—Brinzolamide—glaucoma	0.00167	0.00216	CcSEcCtD
Dolutegravir—Pruritus—Pilocarpine—glaucoma	0.00166	0.00215	CcSEcCtD
Dolutegravir—Mental disorder—Timolol—glaucoma	0.00164	0.00213	CcSEcCtD
Dolutegravir—Dizziness—Dorzolamide—glaucoma	0.00164	0.00213	CcSEcCtD
Dolutegravir—Rash—Brimonidine—glaucoma	0.00164	0.00212	CcSEcCtD
Dolutegravir—Dermatitis—Brimonidine—glaucoma	0.00164	0.00212	CcSEcCtD
Dolutegravir—Dizziness—Travoprost—glaucoma	0.00163	0.00212	CcSEcCtD
Dolutegravir—Headache—Brimonidine—glaucoma	0.00163	0.00211	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Clonidine—glaucoma	0.00162	0.00209	CcSEcCtD
Dolutegravir—Fatigue—Clonidine—glaucoma	0.00161	0.00209	CcSEcCtD
Dolutegravir—Dizziness—Brinzolamide—glaucoma	0.00161	0.00209	CcSEcCtD
Dolutegravir—Nausea—Acetazolamide—glaucoma	0.00161	0.00208	CcSEcCtD
Dolutegravir—Diarrhoea—Pilocarpine—glaucoma	0.0016	0.00208	CcSEcCtD
Dolutegravir—Nervous system disorder—Betaxolol—glaucoma	0.0016	0.00207	CcSEcCtD
Dolutegravir—UGT1A1—Phase II conjugation—GSTM1—glaucoma	0.00159	0.007	CbGpPWpGaD
Dolutegravir—Skin disorder—Betaxolol—glaucoma	0.00158	0.00205	CcSEcCtD
Dolutegravir—Vomiting—Dorzolamide—glaucoma	0.00158	0.00204	CcSEcCtD
Dolutegravir—Rash—Dorzolamide—glaucoma	0.00157	0.00203	CcSEcCtD
Dolutegravir—Dermatitis—Dorzolamide—glaucoma	0.00156	0.00202	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—TGFB2—glaucoma	0.00156	0.00687	CbGpPWpGaD
Dolutegravir—Rash—Travoprost—glaucoma	0.00156	0.00202	CcSEcCtD
Dolutegravir—Dermatitis—Travoprost—glaucoma	0.00156	0.00202	CcSEcCtD
Dolutegravir—Headache—Dorzolamide—glaucoma	0.00156	0.00201	CcSEcCtD
Dolutegravir—Vomiting—Brinzolamide—glaucoma	0.00155	0.00201	CcSEcCtD
Dolutegravir—Dizziness—Pilocarpine—glaucoma	0.00155	0.00201	CcSEcCtD
Dolutegravir—Headache—Travoprost—glaucoma	0.00155	0.002	CcSEcCtD
Dolutegravir—Nausea—Brimonidine—glaucoma	0.00154	0.002	CcSEcCtD
Dolutegravir—Rash—Brinzolamide—glaucoma	0.00154	0.00199	CcSEcCtD
Dolutegravir—Dermatitis—Brinzolamide—glaucoma	0.00154	0.00199	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Clonidine—glaucoma	0.00153	0.00198	CcSEcCtD
Dolutegravir—Headache—Brinzolamide—glaucoma	0.00153	0.00198	CcSEcCtD
Dolutegravir—Vomiting—Pilocarpine—glaucoma	0.00149	0.00193	CcSEcCtD
Dolutegravir—Abdominal pain—Clonidine—glaucoma	0.00148	0.00192	CcSEcCtD
Dolutegravir—Rash—Pilocarpine—glaucoma	0.00148	0.00191	CcSEcCtD
Dolutegravir—Dermatitis—Pilocarpine—glaucoma	0.00148	0.00191	CcSEcCtD
Dolutegravir—Insomnia—Betaxolol—glaucoma	0.00147	0.00191	CcSEcCtD
Dolutegravir—Nausea—Dorzolamide—glaucoma	0.00147	0.00191	CcSEcCtD
Dolutegravir—Headache—Pilocarpine—glaucoma	0.00147	0.0019	CcSEcCtD
Dolutegravir—Nausea—Travoprost—glaucoma	0.00147	0.0019	CcSEcCtD
Dolutegravir—Vertigo—Timolol—glaucoma	0.00147	0.0019	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—GSTT1—glaucoma	0.00146	0.00643	CbGpPWpGaD
Dolutegravir—Nausea—Brinzolamide—glaucoma	0.00145	0.00188	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.00143	0.00628	CbGpPWpGaD
Dolutegravir—Gastrointestinal disorder—Betaxolol—glaucoma	0.00141	0.00182	CcSEcCtD
Dolutegravir—Fatigue—Betaxolol—glaucoma	0.00141	0.00182	CcSEcCtD
Dolutegravir—Nausea—Pilocarpine—glaucoma	0.00139	0.0018	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00138	0.00179	CcSEcCtD
Dolutegravir—Hypersensitivity—Clonidine—glaucoma	0.00138	0.00179	CcSEcCtD
Dolutegravir—Asthenia—Clonidine—glaucoma	0.00134	0.00174	CcSEcCtD
Dolutegravir—Pruritus—Clonidine—glaucoma	0.00133	0.00172	CcSEcCtD
Dolutegravir—Nervous system disorder—Timolol—glaucoma	0.00131	0.00169	CcSEcCtD
Dolutegravir—Skin disorder—Timolol—glaucoma	0.00129	0.00168	CcSEcCtD
Dolutegravir—Diarrhoea—Clonidine—glaucoma	0.00128	0.00166	CcSEcCtD
Dolutegravir—Dizziness—Clonidine—glaucoma	0.00124	0.0016	CcSEcCtD
Dolutegravir—Insomnia—Timolol—glaucoma	0.0012	0.00156	CcSEcCtD
Dolutegravir—Hypersensitivity—Betaxolol—glaucoma	0.0012	0.00156	CcSEcCtD
Dolutegravir—Vomiting—Clonidine—glaucoma	0.00119	0.00154	CcSEcCtD
Dolutegravir—Rash—Clonidine—glaucoma	0.00118	0.00153	CcSEcCtD
Dolutegravir—Dermatitis—Clonidine—glaucoma	0.00118	0.00153	CcSEcCtD
Dolutegravir—Headache—Clonidine—glaucoma	0.00117	0.00152	CcSEcCtD
Dolutegravir—Asthenia—Betaxolol—glaucoma	0.00117	0.00151	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—CYP1B1—glaucoma	0.00117	0.00512	CbGpPWpGaD
Dolutegravir—Pruritus—Betaxolol—glaucoma	0.00115	0.00149	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Timolol—glaucoma	0.00115	0.00149	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP1B1—glaucoma	0.00115	0.00505	CbGpPWpGaD
Dolutegravir—Fatigue—Timolol—glaucoma	0.00115	0.00149	CcSEcCtD
Dolutegravir—Diarrhoea—Betaxolol—glaucoma	0.00112	0.00144	CcSEcCtD
Dolutegravir—Nausea—Clonidine—glaucoma	0.00111	0.00144	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Timolol—glaucoma	0.00109	0.00141	CcSEcCtD
Dolutegravir—Dizziness—Betaxolol—glaucoma	0.00108	0.0014	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—GSTM1—glaucoma	0.00106	0.00467	CbGpPWpGaD
Dolutegravir—Abdominal pain—Timolol—glaucoma	0.00105	0.00136	CcSEcCtD
Dolutegravir—Vomiting—Betaxolol—glaucoma	0.00104	0.00134	CcSEcCtD
Dolutegravir—Rash—Betaxolol—glaucoma	0.00103	0.00133	CcSEcCtD
Dolutegravir—Dermatitis—Betaxolol—glaucoma	0.00103	0.00133	CcSEcCtD
Dolutegravir—UGT1A1—Metabolism—CA5A—glaucoma	0.00103	0.0045	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NARFL—glaucoma	0.00103	0.0045	CbGpPWpGaD
Dolutegravir—Headache—Betaxolol—glaucoma	0.00102	0.00132	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.00102	0.00447	CbGpPWpGaD
Dolutegravir—Hypersensitivity—Timolol—glaucoma	0.000982	0.00127	CcSEcCtD
Dolutegravir—Nausea—Betaxolol—glaucoma	0.000969	0.00125	CcSEcCtD
Dolutegravir—Asthenia—Timolol—glaucoma	0.000956	0.00124	CcSEcCtD
Dolutegravir—Pruritus—Timolol—glaucoma	0.000943	0.00122	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—GSTM1—glaucoma	0.000932	0.00409	CbGpPWpGaD
Dolutegravir—UGT1A1—Metapathway biotransformation—GSTM1—glaucoma	0.000919	0.00404	CbGpPWpGaD
Dolutegravir—Diarrhoea—Timolol—glaucoma	0.000912	0.00118	CcSEcCtD
Dolutegravir—Dizziness—Timolol—glaucoma	0.000881	0.00114	CcSEcCtD
Dolutegravir—Vomiting—Timolol—glaucoma	0.000847	0.0011	CcSEcCtD
Dolutegravir—Rash—Timolol—glaucoma	0.00084	0.00109	CcSEcCtD
Dolutegravir—Dermatitis—Timolol—glaucoma	0.000839	0.00109	CcSEcCtD
Dolutegravir—Headache—Timolol—glaucoma	0.000835	0.00108	CcSEcCtD
Dolutegravir—Nausea—Timolol—glaucoma	0.000791	0.00102	CcSEcCtD
Dolutegravir—UGT1A1—Metabolism—CA1—glaucoma	0.000501	0.0022	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CTSA—glaucoma	0.000485	0.00213	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CA2—glaucoma	0.000458	0.00201	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—TXN—glaucoma	0.000323	0.00142	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GSTT1—glaucoma	0.00025	0.0011	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ABCA1—glaucoma	0.000199	0.000876	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP1B1—glaucoma	0.000199	0.000876	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GSTM1—glaucoma	0.000159	0.0007	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—MTHFR—glaucoma	0.000141	0.000619	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOE—glaucoma	0.000131	0.000576	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CAV1—glaucoma	0.00013	0.000571	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NOS3—glaucoma	9.82e-05	0.000431	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PTGS2—glaucoma	8.98e-05	0.000395	CbGpPWpGaD
